Publications

Publication: JournalArticle (Originalarbeit in einer wissenschaftlichen Zeitschrift)

ID	Author	Year	Title	Publisher
1192817	Zaman, K.	2011	Combination of bevacizumab and 2-weekly pegylated liposomal doxorubicin as first-line therapy for locally recurrent or metastatic breast cancer : a multicenter, single-arm phase II trial (SAKK 24/06)	Annals of oncology
1194900	Haschke, Manuel; Vitins, Tanja; Lüde, Saskia; Todesco, Liliane; Novakova, Katerina; Herrmann, Richard; Krähenbühl, Stephan	2010	Urinary excretion of carnitine as a marker of proximal tubular damage associated with platin-based antineoplastic drugs	Nephrology, dialysis, transplantation
1193509	Herrmann, R.	2010	Combining gemcitabine, oxaliplatin and capecitabine (GEMOXEL) for patients with advanced pancreatic carcinoma (APC) : a phase I/II trial	Annals of oncology
1196604	Wicki, Andreas; Herrmann, Richard; Christofori, Gerhard	2010	Kras in metastatic colorectal cancer	Swiss Medical Weekly
1194174	Bernhard, J; Dietrich, D; Glimelius, B; Hess, V; Bodoky, G; Scheithauer, W; Herrmann, R	2010	Estimating prognosis and palliation based on tumour marker CA 19-9 and quality of life indicators in patients with advanced pancreatic cancer receiving chemotherapy	British journal of cancer
1196723	Lippert, Eric; Girodon, François; Hammond, Emma; Jelinek, Jaroslav; Reading, N Scott; Fehse, Boris; Hanlon, Katy; Hermans, Mirjam; Richard, Céline; Swierczek, Sabina; Ugo, Valérie; Carillo, Serge; Harrivel, Véronique; Marzac, Christophe; Pietra, Daniela; Sobas, Marta; Mounier, Morgane; Migeon, Marina; Ellard, Sian; Kröger, Nicolaus; Herrmann, Richard; Prchal, Josef T; Skoda, Radek C; Hermouet, Sylvie	2009	Concordance of assays designed for the quantification of JAK2V617F : a multicenter study	Haematologica : journal of hematology
1193484	Rochlitz, Christoph	2009	Tumor-endothelial interaction links the CD44(+)/CD24(-) phenotype with poor prognosis in early-stage breast cancer	Neoplasia
1196729	Cunningham, David; Chau, Ian; Stocken, Deborah D; Valle, Juan W; Smith, David; Steward, William; Harper, Peter G; Dunn, Janet; Tudur-Smith, Catrin; West, Julia; Falk, Stephen; Crellin, Adrian; Adab, Fawzi; Thompson, Joyce; Leonard, Pauline; Ostrowski, Joe; Eatock, Martin; Scheithauer, Werner; Herrmann, Richard; Neoptolemos, John P	2009	Phase III randomized comparison of gemcitabine versus gemcitabine plus capecitabine in patients with advanced pancreatic cancer	Journal of clinical oncology : official journal of the American Society of Clinical Oncology
1197925	Donat, D.; Pesic, J.; Trifunovic, J.; Muzikravic, L.; Tesanovic, S.; Donat, D. D.; Pesic, T.	2008	Adjuvant therapy of HER2-positive breast cancer with trastuzumab	Senologie
1195911	Herrmann, R; Jelic, S; ESMO Guidelines Working Group	2008	Pancreatic cancer: ESMO clinical recommendations for diagnosis, treatment and follow-up	Annals of oncology
1197936	Lindpaintner,L; Grüninger,T; Nega,S; Seidegger,C; Spoendlin, M; Stoll,A; Herrmann,R	2008	Kommunikation und Vernetzung in der Onkologie	Care management
1194721	Laffer, U; Metzger, U; Aeberhard, P; Lorenz, M; Harder, F; Maibach, R; Zuber, M; Herrmann, R	2008	Adjuvant perioperative portal vein or peripheral intravenous chemotherapy for potentially curative colorectal cancer : long-term results of a randomized controlled trial	International journal of colorectal disease
1196425	Hess, Viviane; Glimelius, Bengt; Grawe, Philipp; Dietrich, Daniel; Bodoky, György; Ruhstaller, Thomas; Bajetta, Emilio; Saletti, Piercarlo; Figer, Arie; Scheithauer, Werner; Herrmann, Richard	2008	CA 19-9 tumour-marker response to chemotherapy in patients with advanced pancreatic cancer enrolled in a randomised controlled trial	The Lancet oncology
1194722	Central, European Cooperative Oncology Group	2008	Clinical benefit and quality of life in patients with advanced pancreatic cancer receiving gemcitabine plus capecitabine versus gemcitabine alone : a randomized multicenter phase III clinical trial--SAKK 44/00-CECOG/PAN.1.3.001	Journal of clinical oncology
1196462	Heinrich, Michael C; Joensuu, Heikki; Demetri, George D; Corless, Christopher L; Apperley, Jane; Fletcher, Jonathan A; Soulieres, Denis; Dirnhofer, Stephan; Harlow, Amy; Town, Ajia; McKinley, Arin; Supple, Shane G; Seymour, John; Di Scala, Lilla; van Oosterom, Allan; Herrmann, Richard; Nikolova, Zariana; McArthur, And Grant; Imatinib Target Exploration Consortium Study B2225	2008	Phase II, open-label study evaluating the activity of imatinib in treating life-threatening malignancies known to be associated with imatinib-sensitive tyrosine kinases	Clinical cancer research
1195365	Koeberle, Dieter; Saletti, Piercarlo; Borner, Markus; Gerber, Daniela; Dietrich, Daniel; Caspar, Clemens B; Mingrone, Walter; Beretta, Kurt; Strasser, Florian; Ruhstaller, Thomas; Mora, Oreste; Herrmann, Richard; Swiss Group for Clinical Cancer Research	2008	Patient-reported outcomes of patients with advanced biliary tract cancers receiving gemcitabine plus capecitabine : a multicenter, phase II trial of the swiss group for clinical cancer research	Journal of clinical oncology

JournalItem (Kommentare, Editorials, Rezensionen, Urteilsanmerk., etc. in einer wissensch. Zeitschr.

ID	Author	Year	Title	Publisher
1197694	Brauchli, Peter; Thürlimann, Beat; Crowe, Susanne N; Herrmann, Richard	2010	What is the value of the 21-gene recurrence score?	Journal of clinical oncology
1197747	Laffer, Urban	2009	Perioperative and adjuvant chemotherapy in colon cancer : results of SAKK trial 40/93	International journal of colorectal disease